BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22977500)

  • 21. The effectiveness of a pain management programme on pain control and quality of life in patients with metastatic cancer.
    Prisutkul A; Dechaphunkul A; Arundorn T; Songserm M; Ruangdam A; Sathitruangsak C
    Int J Palliat Nurs; 2022 Sep; 28(9):436-444. PubMed ID: 36151980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of Japanese Traditional Medicine, Ninjin-Youei-To(TJ-108), on the Quality of Life of Patients with Non-Small Cell Lung Cancer Receiving Outpatient Chemotherapy].
    Ishiura Y; Shiba Y; Terasaki Y; Yoneyama S; Yamada K; Hinoue Y; Ishida Y; Segawa M; Doki Y; Kasahara K; Fujimura M; Nakao S; Tamaki T; Shimizu T; Nomura S
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1071-1074. PubMed ID: 30042275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staged versus conventional nursing for patients receiving chemotherapy for advanced non-small cell lung cancer: a before and after study.
    Zhu L; Chen L; Kan H; Cai P
    Ann Palliat Med; 2021 Jan; 10(1):250-257. PubMed ID: 33474963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life outcomes in left ventricular assist system inpatients and outpatients.
    Dew MA; Kormos RL; Winowich S; Nastala CJ; Borovetz HS; Roth LH; Sanchez J; Griffith BP
    ASAIO J; 1999; 45(3):218-25. PubMed ID: 10360727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
    Hirose C; Fujii H; Iihara H; Ishihara M; Nawa-Nishigaki M; Kato-Hayashi H; Ohata K; Sekiya K; Kitahora M; Matsuhashi N; Takahashi T; Okuda K; Naruse M; Ishihara T; Sugiyama T; Yoshida K; Suzuki A
    Support Care Cancer; 2020 Dec; 28(12):5943-5952. PubMed ID: 32281034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in quality of life and health status in patients with extracorporeal life support: A prospective longitudinal study.
    Chen KH; Chen YT; Yeh SL; Weng LC; Tsai FC
    PLoS One; 2018; 13(5):e0196778. PubMed ID: 29746522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Visser S; de Mol M; Cheung K; van Toor JJ; van Walree NC; Stricker BH; Den Oudsten BL; Aerts JGJV
    Clin Lung Cancer; 2018 Jul; 19(4):e503-e516. PubMed ID: 29705017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital.
    Ramasubbu SK; Pasricha RK; Nath UK; Rawat VS; Das B
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1312. PubMed ID: 33295136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.
    Shun SC; Chen CH; Sheu JC; Liang JD; Yang JC; Lai YH
    Oncologist; 2012; 17(5):732-9. PubMed ID: 22511265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of inpatient physical therapy compared to outpatient physical therapy in older adults after total hip replacement in the post-discharge period: a systematic review.
    Klugarova J; Klugar M; Mareckova J; Gallo J; Kelnarova Z
    JBI Database System Rev Implement Rep; 2016 Jan; 14(1):174-209. PubMed ID: 26878927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.
    Berger AM; Lockhart K; Agrawal S
    Oncol Nurs Forum; 2009 Sep; 36(5):563-70. PubMed ID: 19726396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Quality of Life and Emotional Well-being in Breast, Colon, and Lung Cancer Patients During Outpatient Adjuvant Chemotherapy: A Longitudinal Study.
    Ulibarri-Ochoa A; Ruiz-de-Alegría B; López-Vivanco G; García-Vivar C; Iraurgi I
    Cancer Nurs; 2023 Mar-Apr 01; 46(2):E99-E109. PubMed ID: 35283472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalization-induced exacerbation of the ill effects of chemotherapy on rest-activity rhythm and quality of life of breast cancer patients: a prospective and comparative cross-sectional follow-up study.
    Sultan A; Pati AK; Choudhary V; Parganiha A
    Chronobiol Int; 2018 Oct; 35(11):1513-1532. PubMed ID: 29985659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
    Velikova G; Morden JP; Haviland JS; Emery C; Barrett-Lee P; Earl H; Bloomfield D; Brunt AM; Canney P; Coleman R; Verrill M; Wardley A; Bertelli G; Ellis P; Stein R; Bliss JM; Cameron D;
    Lancet Oncol; 2023 Dec; 24(12):1359-1374. PubMed ID: 37926100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Associated With Discharge Planning Practices for Patients Receiving Inpatient Psychiatric Care.
    Smith TE; Haselden M; Corbeil T; Wall MM; Tang F; Essock SM; Frimpong E; Goldman ML; Mascayano F; Radigan M; Schneider M; Wang R; Dixon LB; Olfson M
    Psychiatr Serv; 2021 May; 72(5):498-506. PubMed ID: 33657838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need and demand for nutritional counselling and their association with quality of life, nutritional status and eating-related distress among patients with cancer receiving outpatient chemotherapy: a cross-sectional study.
    Koshimoto S; Arimoto M; Saitou K; Uchibori M; Hashizume A; Honda A; Amano K; Nakajima Y; Uetake H; Matsushima E
    Support Care Cancer; 2019 Sep; 27(9):3385-3394. PubMed ID: 30643989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study.
    Fujii H; Koda M; Sadaka S; Ohata K; Kato-Hayashi H; Iihara H; Kobayashi R; Ishihara T; Uemura S; Iwashita T; Hayashi H; Sugiyama T; Shimizu M; Suzuki A
    J Pharm Health Care Sci; 2021 Aug; 7(1):27. PubMed ID: 34334136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice.
    Lithoxopoulou H; Zarogoulidis K; Bostantzopoulou S; Eleftheriadou E; Zarogoulidis P; Huang H; Porpodis K; Kioumis I; Tsiouda T; Yarmus L; Kontakiotis T
    Support Care Cancer; 2014 Aug; 22(8):2177-83. PubMed ID: 24652050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer.
    Akin S; Kas Guner C
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12898. PubMed ID: 30039883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.